circKLHL24 blocked the progression of breast cancer by activating ALX4 through targeting miR-1204, which might be a novel perspective to understand the pathogenesis of breast cancer.
circKLHL24 Blocks Breast Cancer Development by Regulating the miR-1204/ALX4 Network.